Cargando…
Combination of Everolimus and Bortezomib Inhibits the Growth and Metastasis of Bone and Soft Tissue Sarcomas via JNK/p38/ERK MAPK and AKT Pathways
SIMPLE SUMMARY: High-grade bone and soft tissue sarcomas are known for high recurrence and low survival rates. New drug development is costly and time-consuming. Instead, new combinations of existing drugs may offer novel anticancer strategies. We previously demonstrated that the combination of the...
Autores principales: | Nakamura, Koichi, Asanuma, Kunihiro, Okamoto, Takayuki, Iino, Takahiro, Hagi, Tomohito, Nakamura, Tomoki, Sudo, Akihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177427/ https://www.ncbi.nlm.nih.gov/pubmed/37173935 http://dx.doi.org/10.3390/cancers15092468 |
Ejemplares similares
-
Soluble programmed death-ligand 1 rather than PD-L1 on tumor cells effectively predicts metastasis and prognosis in soft tissue sarcomas
por: Asanuma, Kunihiro, et al.
Publicado: (2020) -
Expression of Interleukin-6 and the Interleukin-6 Receptor Predicts the Clinical Outcomes of Patients with Soft Tissue Sarcomas
por: Nakamura, Koichi, et al.
Publicado: (2020) -
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan
por: Nakamura, Tomoki, et al.
Publicado: (2020) -
Is Lymphocyte C-Reactive Protein Ratio Useful for Predicting Survival in Patients with Non-Metastatic Soft Tissue Sarcoma?
por: Nakamura, Tomoki, et al.
Publicado: (2022) -
The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas
por: Hagi, Tomohito, et al.
Publicado: (2017)